TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Dividend Stocks
An Opportunity for Excess Profits in the Marijuana Industry
Investing
2 Reasons Aphria Inc. Makes Sense
Investing
What’s Next for the Marijuana Industry After Trudeau’s Proposed Legislation?
Investing
Canopy Growth Corp.: Should You Buy at $10?
Investing
Canopy Growth Corp. Continues to Grow
Dividend Stocks
What Tim Hortons Can Teach Canopy Growth Corp. Investors
Investing
Canopy Growth Corp.: Not a Buy on Legalization News
Investing
Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp. as Canada’s Favourite Marijuana Stock?
Stocks for Beginners
Investors: Beware of the 52-Week-High Fallacy
Metals and Mining Stocks
Canopy Growth Corp. and Potash Corporation of Saskatchewan Inc.: 2 Peas in a Pod?